Compare AbbVie Inc (ABBV) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Occidental Petroleum Corporation — how do they compare? AbbVie Inc trades at $254.05 (market cap $449.91B), while Occidental Petroleum Corporation trades at $53.58 (market cap $51.40B). The key difference: AbbVie Inc is far larger — about 8.8× Occidental Petroleum Corporation's market cap, and AbbVie Inc pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| ABBV | OXY | |
|---|---|---|
Market Cap | $449.91B | $51.40B |
Sector | Health | Energy |
52-Week High | $261.07 | $66.24 |
52-Week Low | $184.85 | $38.92 |
Enterprise Value | $513.38B | $72.49B |
Dividend Yield | 2.72% | 2.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.92, down 0.72% on the day, with strong technical support at $251 and resistance at $258. The stock shows bullish momentum with recent earnings beats and a consensus analyst price target of $266.33. Revenue grew to $61.16B in 2025, though net margins compressed to 5.79%. Key growth drivers include Skyrizi and Rinvoq offsetting Humira declines, supported by positive Phase 2 data for ELAHERE in ovarian cancer (PRNewsWire, 2026-04-12).
Outlook remains positive with immunology portfolio strength and dividend growth, but risks include patent cliffs in the 2030s and high debt levels. Institutional buying and 68% analyst buy ratings suggest confidence, though valuation multiples like P/E of 124.83 warrant caution. Near-term catalysts include Q2 2026 earnings expected at $3.79 EPS.
Occidental Petroleum (OXY) trades at $51.68, up 5.66% with strong recent earnings beats. The stock shows bearish technical signals but attractive valuation with EV/EBITDA of 6.34x. Recent CEO transition and debt reduction efforts are key developments, while oil price volatility remains a primary factor. Analyst consensus leans positive with 48% buy ratings and $66.86 price target suggesting 29% upside potential from current levels.
OXY presents value opportunity with reasonable valuation and consistent earnings outperformance, though exposure to oil prices and execution risks under new leadership warrant caution. The company's pivot toward carbon capture technologies and Permian Basin strength provide long-term growth catalysts, but near-term performance depends on commodity price stability and successful debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
